Aeolus Pharmaceuticals, Inc.
AOLS · OTC
6/30/2017 | 3/31/2017 | 12/31/2016 | 9/30/2016 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -89.9% | 55.4% | -84.8% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3,169.2% | -360.5% | -489.2% | -80.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -7,300% | -802.3% | -1,309.6% | -187.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -7,300% | -802.3% | -1,309.6% | -187.4% |
| EPS Diluted | -0.006 | -0.007 | -0.007 | -0.007 |
| % Growth | 8.8% | 4.2% | -6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |